Investigation of Remimazolam in Children Undergoing Sedation for Medical Procedures

PHASE2/PHASE3Active, not recruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

November 15, 2021

Primary Completion Date

October 31, 2027

Study Completion Date

October 31, 2027

Conditions
Pediatric ALL
Interventions
DRUG

Remimazolam

Remimazolam for intravenous sedation

Trial Locations (8)

15224

University of Pittsburgh Medical Center - Children's Hospital of Pittsburgh, Pittsburgh

55455

University of Minnesota Masonic Children's Hospital, Minneapolis

77030

Texas Children's Hospital, Houston

94306

Stanford University, Palo Alto

95817

University of California Davis Children's Hospital, Sacramento

02115

Boston Children's Hospital, Boston

Unknown

Rigshospitalet, Copenhagen

Odense Universitetshospital, Odense

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

Paion UK Ltd.

INDUSTRY

lead

Acacia Pharma Ltd

INDUSTRY